Crinetics Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

43.74 +0.35 (+0.81%) USD | NASDAQ | Feb 26, 16:00

44.00 +0.26 (+0.59%) After-Hours: 07:37

View Net Non-Operating Interest Income Expense (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	Upgrade
GT Biopharma, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
Sutro Biopharma, Inc.	Upgrade
Gossamer Bio, Inc.	Upgrade